Maintenance Golimumab Treatment in Pediatric UC Patients With Moderately to Severely Active UC: PURSUIT PEDS PK Long-Term Study Results.

Jeffrey S Hyams,Christopher D O’Brien,Lakshmi Padgett,Joel R Rosh,Dan Turner,Genevieve Veereman,Anne M Griffiths,Melvin B Heyman,Ghassan Wahbeh,Omoniyi J Adedokun,Richard S Strauss,John P Lynch,Daphne Chan

Crohn's & colitis 360（2020）

引用 3|浏览11

暂无评分

摘要

Among children with ulcerative colitis who initially responded to golimumab induction and received q4w maintenance treatment in the long-term extension, 50% showed continued clinical benefit through 2 years. No new safety signals were observed.

查看译文

关键词

clinical remission,clinical response,ulcerative colitis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要